# FDA recall D-1409-2014

> **Pfizer Us Pharmaceutical Group** · Class II · drug recall initiated 2014-04-16.

## Product

Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc.,  NDC 0008-1211-30

## Reason for recall

Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1409-2014
- **Recalling firm:** Pfizer Us Pharmaceutical Group
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-04-16
- **Report date:** 2014-07-02
- **Termination date:** 2016-09-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1409-2014

## Citation

> AI Analytics. FDA recall D-1409-2014. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-1409-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
